Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Anika Koop"'
Autor:
Michael Max Sachse, Hanna Blasig, Carolin Bender, Thomas Eigentler, Julia Hiernickel, Jessica C. Hassel, Imke Satzger, Anika Koop, Ralf Gutzmer
Publikováno v:
Melanoma Research. 27:321-325
Significant progress has been made in the treatment of metastatic melanoma during the last years. Approval of immune-checkpoint inhibitors and targeted therapies has been achieved recently. The sequencing of these therapies is an important issue. Her
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a71ca0f11ef4fa5f0692303c0fd863d4
https://doi.org/10.1097/cmr.0000000000000341
https://doi.org/10.1097/cmr.0000000000000341
Autor:
Ralf Gutzmer, Claudia Pföhler, Lucie Heinzerling, Friedegund Meier, Patrick Terheyden, Anika Koop, Katharina C. Kähler, Anja Gesierich, Imke Satzger, Jessica C. Hassel, Selma Ugurel, Elisabeth Livingstone, Lisa Zimmer
Aim Programmed cell death protein 1 (PD-1) inhibitors are a common treatment strategy for metastatic melanoma and other tumour entities. Clinical trials usually exclude patients with preexisting autoimmune diseases, thus experience with PD-1 inhibito
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19f231eef4f538a01b10c7b953cfdcb2
https://www.ncbi.nlm.nih.gov/pubmed/28214654
https://www.ncbi.nlm.nih.gov/pubmed/28214654
Publikováno v:
British Journal of Dermatology. 170:220-222
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15e028df71d77af3fa46e4322de33cf7
https://doi.org/10.1111/bjd.12615
https://doi.org/10.1111/bjd.12615